> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Priority Voucher Used on Tremfya sBLA
- URL: https://www.fdaweb.com/priority-voucher-used-on-tremfya-sbla/
- Published: 2024-10-10T12:00:00.000Z
- Updated: 2026-09-14T14:43:45.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157955

*Federal Register* notice: FDA is announcing that it approved a product submission that redeemed a priority review voucher — Johnson & Johnson’s supplemental BLA for Tremfya (guselkumab) for treating adults with moderately to severely active ulcerative colitis. The agency is required to publish a notice when a priority review voucher is issued and when it is redeemed. To view the notice, click [here](https://public-inspection.federalregister.gov/2024-23629.pdf?ref=fdaweb.com).